Search research articles

Search research articles

Related Experiment Videos

Tezosentan attenuates organ injury and mesenteric blood flow decrease in endotoxemia and cecal ligation and puncture.

Aysen Erdem¹, A Meltem Sevgili, Filiz Akbiyik

¹Department of Physiology, Faculty of Medicine, Hacettepe University, Ankara, Turkey.

The Journal of Surgical Research

|June 23, 2007

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

<i>Pelargonium graveolens</i> Essential Oil Suppresses Proliferation and Migration and Modulates Mesenchymal-Associated Cellular Functions in Human Endometriotic Cells.

Cells·2026

Same author

The Clinical Importance of Component-Based Diagnostic Test in Patients Planned for Venom Immunotherapy.

International archives of allergy and immunology·2026

Same author

The effect of preemptive use of nonsteroidal anti-inflammatory drug on inflammation, oxidative stress, and wound healing.

Scientific reports·2026

Same author

Effects of food and gastrointestinal secretions on intestinal integrity in an experimental rat model.

Experimental and therapeutic medicine·2025

Same author

The Predictive Role of Thiol/Disulfide Homeostasis as an Oxidative Stress Parameter in Sarcopenic Obesity.

Medicina (Kaunas, Lithuania)·2025

Same author

Acute Anxiolytic Effects of Salvia Heldreichiana Essential Oil in Rats: Reduction in Serum Cortisol.

Brain and behavior·2025

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Tezosentan, an endothelin receptor antagonist, improved mesenteric blood flow and reduced organ injury in septic shock models. It offers a promising treatment option beyond free radical blockade.

Area of Science:

Pharmacology
Critical Care Medicine
Experimental Pathology

Background:

Septic shock leads to decreased mesenteric blood flow and organ damage from free radicals.
Endothelin receptor blockade shows potential therapeutic benefits.
Tezosentan, a dual endothelin receptor antagonist, was investigated for its effects on septic shock.

Purpose of the Study:

To evaluate the efficacy of tezosentan in experimental models of septic shock.
To assess tezosentan's impact on mesenteric blood flow and organ injury.
To explore the mechanisms underlying tezosentan's protective effects.

Main Methods:

Two septic shock models were used: Escherichia coli endotoxin (ETX) and cecal ligation and puncture (CLP).
Mice received tezosentan or saline, and mesenteric blood flow was measured.

Related Experiment Videos

Histopathological examination of spleen, liver, and kidneys was performed, along with biochemical analyses.

Main Results:

Tezosentan successfully blocked the decrease in mesenteric blood flow in both ETX and CLP models.
Histopathological organ injury was significantly attenuated by tezosentan treatment.
Tezosentan's effect on oxidative stress markers (glutathione, thiobarbituric acid reacting substances, myeloperoxidase) was inconsistent but suggested partial involvement in liver protection.

Conclusions:

Tezosentan is a potential treatment for septic shock, effectively mitigating mesenteric ischemia and organ damage.
The protective mechanisms of tezosentan appear to involve pathways beyond the direct blockade of free radical damage.
Further investigation into tezosentan's multifaceted therapeutic actions is warranted.